Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 5Genitourinary 4Breast 4Sarcoma 3Gastrointestinal 3CNS 2Plasma cell 1Other solid neoplasm 1Other hematologic neoplasm 1Myeloid 1Head & Neck 1Gynecologic 1Dermatologic 1

Conditions

Myelodysplastic Syndromes 1Mesothelioma, Malignant 1Lung Neoplasms 1Leukemia 1Congenital Abnormalities 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 296Cytarabine 261fludarabine phosphate 218Rituximab 195fludarabine 182Methotrexate 152Whole-Body Irradiation 140Mycophenolic Acid 124Azacitidine 122Tacrolimus 116Busulfan 110Filgrastim 104Granulocyte Colony-Stimulating Factor 98Etoposide 91Peripheral Blood Stem Cell Transplantation 90Dexamethasone 89Vincristine 88Melphalan 80Cyclosporine 74Lenalidomide 73Daunorubicin 70Decitabine 69Clofarabine 69Antilymphocyte Serum 67Calcium Dobesilate 61venetoclax 60Doxorubicin 58Imatinib Mesylate 57Alemtuzumab 56ibrutinib 55

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Immunoenzyme Techniques × Other hematologic neoplasm × Clear all
NCT00398138 2016-03-02

Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
22 enrolled 7 charts
MyeloidOther hematologic neoplasmOther solid neoplasmThoracic

Congenital Abnormalities, Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Leukemia, Lung Neoplasms, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡